文献速递肝病消化道肿瘤与早癌

微小RNA-206通过驱动库普弗细胞M1极化促进CD8+ T细胞募集

MicroRNA-206 promotes the recruitment of CD8+ T cells by driving M1 polarisation of Kupffer cells.
PubMed 文献 · Gut · 2021-10-27

该研究在AKT/Ras水动力注射诱导的肝细胞癌(HCC)小鼠模型中,发现库普弗细胞(KCs)M2极化促进HCC发展并伴随微小RNA-206生物合成受损。微小RNA-206通过靶向Klf4增强CCL2产生,驱动巨噬细胞M1极化并经CCR2募集细胞毒性T细胞(CTLs),KCs特异性表达微小RNA-206完全预防HCC,而对照小鼠100%死于HCC。

要点

  • KCs的M2极化是AKT/Ras小鼠HCC发生的主要促进因素。
  • 微小RNA-206通过靶向Klf4上调CCL2,驱动巨噬细胞M1极化并募集CD8+ T细胞。
  • KCs特异性表达微小RNA-206可完全预防HCC,提示其免疫治疗潜力。

核心结论

  • KCs的M2极化是AKT/Ras小鼠HCC的主要促进因素。
  • 微小RNA-206通过驱动KCs M1极化促进CD8+ T细胞募集并预防HCC,提示其潜在免疫治疗用途。

研究设计与样本

  • 研究采用FVB/NJ小鼠经水动力注射AKT/Ras和Sleeping Beauty转座子诱导HCC。
  • 使用Mini-circle和Sleeping Beauty在小鼠KCs中过表达微小RNA-206。
  • 采用流式细胞术和免疫染色评估免疫系统变化。

主要发现

  • 水动力注射AKT/Ras驱动KCs M2极化、细胞毒性T细胞(CTLs)耗竭并促进HCC发展。
  • KCs的M1向M2转变损害微小RNA-206生物合成。
  • 微小RNA-206通过靶向Klf4增强M1标志物(包括CCL2)产生,促进巨噬细胞M1极化。
  • 微小RNA-206介导的CCL2增加通过CCR2促进CTLs的肝脏募集。
  • 在AKT/Ras小鼠中,KC特异性表达微小RNA-206驱动KCs M1极化、肝脏CTLs募集并完全预防HCC,而对照小鼠100%死于HCC。

关键数值与推荐

  • 在AKT/Ras小鼠中,KC特异性表达微小RNA-206完全预防HCC,对照小鼠100%死于HCC。

临床怎么用

  • 微小RNA-206可能作为HCC的免疫治疗策略,通过驱动KCs M1极化和募集CD8+ T细胞发挥作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Kupffer cells (KCs) protect against hepatocellular carcinoma (HCC) by communicating with other immune cells. However, the underlying mechanism(s) of this process is incompletely understood. DESIGN: FVB/NJ mice were hydrodynamically injected with AKT/Ras and Sleeping Beauty transposon to induce HCC. Mini-circle and Sleeping Beauty were used to overexpress microRNA-206 in KCs of mice. Flow cytometry and immunostaining were used to evaluate the change in the immune system. RESULTS: Hydrodynamic injection of AKT/Ras into mice drove M2 polarisation of KCs and depletion of cytotoxic T cells (CTLs) and promoted HCC development. M1-to-M2 transition of KCs impaired microRNA-206 biogenesis. By targeting Klf4 (kruppel like factor 4) and, thereby, enhancing the production of M1 markers including C-C motif chemokine ligand 2 (CCL2), microRNA-206 promoted M1 polarisation of macrophages. Indeed, microRNA-206-mediated increase of CCL2 facilitated hepatic recruitment of CTLs via CCR2. Disrupting each component of the KLF4/CCL2/CCR2 axis impaired the ability of microRNA-206 to drive M1 polarisation of macrophages and recruit CTLs. In AKT/Ras mice, KC-specific expression of microRNA-206 drove M1 polarisation of KCs and hepatic recruitment of CTLs and fully prevented HCC, while 100% of control mice died from HCC. Disrupting the interaction between microRNA-206 and Klf4 in KCs and depletion of CD8+ T cells impaired the ability of miR-206 to prevent HCC. CONCLUSIONS: M2 polarisation of KCs is a major contributor of HCC in AKT/Ras mice. MicroRNA-206, by driving M1 polarisation of KCs, promoted the recruitment of CD8+ T cells and prevented HCC, suggesting its potential use as an immunotherapeutic approach.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Liu N, Wang X, Steer CJ, et al. MicroRNA-206 promotes the recruitment of CD8+ T cells by driving M1 polarisation of Kupffer cells. Gut. 2021. PMID: 34706869. doi:10.1136/gutjnl-2021-324170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。